INTRODUCTION
The skin forms an essential structural and immunological barrier protecting the organism from water loss and from mechanical, chemical, and microbial challenges. A tightly regulated crosstalk between epithelial, mesenchymal, and immune cells is essential for both the maintenance of a healthy skin homeostasis and its reestablishment after injury. Disruption of skin homeostasis results in chronic inflammatory skin diseases such as psoriasis. Psoriatic skin inflammation evolves through interactions between epidermal keratinocytes and cells of the immune system (Nestle et al., 2009) . Although the immune mechanisms contributing to cutaneous inflammation in psoriatic skin have been extensively characterized, the factors responsible for triggering the initiation of skin inflammation are not known. Although it is generally believed that T lymphocytes and dendritic cells contribute to its pathogenesis in an essential manner (Lowes et al., 2005; Nickoloff and Wrone-Smith, 1999) , the contribution of epidermal keratinocytes to the onset of psoriasis remains poorly understood.
The efficacy of tumor necrosis factor (TNF)-neutralizing drugs in the treatment of psoriasis demonstrates an essential role for TNF in its pathogenesis (Lowes et al., 2007) . TNF is a highly potent proinflammatory cytokine (Apostolaki et al., 2010) . The ubiquitously expressed TNF receptor 1 (TNFR1) mediates the majority of TNF responses by activating intracellular signaling cascades inducing inflammation but also cell death (Walczak, 2011) . However, the molecular mechanisms responsible for its pathogenic role and the cellular targets of TNF in psoriasis remain unknown. More recently, cytokines of the interleukin-10 (IL-10) family, including , have been implicated in the pathogenesis of psoriasis (Kunz et al., 2006; Leng et al., 2011; Rømer et al., 2003; Weiss et al., 2004; Wolk et al., 2009a) . Increased expression of IL-19, IL-20, IL-22, and IL-24 was detected in psoriatic compared to normal skin (Kunz et al., 2006; Rømer et al., 2003; Wang et al., 2012; Weiss et al., 2004; Wolk et al., 2009b) . In the skin, IL-22 is produced mainly by T cells, whereas are produced by keratinocytes, myeloid cells, and T cells (Conti et al., 2003; Kunz et al., 2006; Zheng et al., 2007) . The receptors for are expressed at high amounts in keratinocytes and signal primarily by activating signal transducer and activator of transcription 3 (STAT3) (Dumoutier et al., 2001; Kunz et al., 2006; Parrish-Novak et al., 2002) . STAT3 is overexpressed and activated in lesional psoriatic skin (Sano et al., 2005; Wolk et al., 2009a) , and transgenic expression of constitutively active STAT3 in epidermal keratinocytes induced psoriasis-like skin inflammation in mice (Sano et al., 2005) , suggesting an important role for epidermal STAT3 signaling in psoriasis.
We showed previously that nuclear factor kappa B (NF-kB) inhibition in keratinocytes by deletion of IkB kinase 2 (K14-Cre Ikk2 fl/fl ) (Pasparakis et al., 2002) or by transgenic IkBa superrepressor expression (K5-IkBaSR) (van Hogerlinden et al., 1999) triggers inflammatory skin lesions in mice. Histologically detectable signs of inflammation appear between postnatal days P3 to P4 in the epidermis of K14-Cre Ikk2 fl/fl mice and rapidly progress to a severe inflammatory skin condition, resulting in the death of all animals between P8 and P10. Skin inflammation in K5-IkBaSR mice starts around 3-4 weeks after birth and progresses more slowly than in the K14-Cre Ikk2 fl/fl mice. The skin lesions induced by epidermis-specific NF-kB inhibition in these mouse models closely resemble human psoriasis, both clinically and histologically. They consist of widespread scaly plaques, which upon histological analysis show acanthosis, hyperkeratosis, dilation of dermal blood vessels, and infiltration by a mixed inflammatory infiltrate with neutrophils forming aggregates in the upper epidermis (Pasparakis et al., 2002; van Hogerlinden et al., 1999) . Genetic ablation of TNFR1 in the whole body prevents the development of inflammatory skin lesions in both the K14-Cre Ikk2 fl/fl and the K5-IkBaSR mice (Lind et al., 2004; Pasparakis et al., 2002) , demonstrating that TNF regulates the pathogenesis of skin inflammation in these models similarly to psoriasis in humans. Skin inflammation in K14-Cre Ikk2 fl/fl mice occurs independently of ab T cells but requires the presence of macrophages in the dermis (Stratis et al., 2006) . Here we investigated how keratinocyte-intrinsic inhibition of NF-kB causes psoriasis-like skin inflammation. Our study uncovers a mechanism that links NF-kB, TNF, IL-24, and STAT3 signaling in epidermal keratinocytes to the initiation of psoriasis-like skin inflammation in mice. We also provide evidence that a similar mechanism could be implicated in the early stages of the development of skin inflammation in human psoriasis.
RESULTS

TNFR1 in Keratinocytes Triggers Skin Inflammation in
Mice with Epidermis-Specific NF-kB Inhibition To address whether TNFR1 signaling in epidermal keratinocytes is needed for the development of skin inflammation in K14-Cre Ikk2 fl/fl mice, the mice were crossed with animals carrying ''floxed'' TNFR1 alleles to generate mice lacking both IKK2 and TNFR1 specifically in keratinocytes (K14-Cre Ikk2 fl/fl Tnfr1 fl/fl ).
Flow cytometry analysis of TNFR1 expression confirmed efficient deletion of TNFR1 in epidermal keratinocytes in K14-Cre Ikk2 fl/fl Tnfr1 fl/fl mice ( Figure 1A ). In contrast to K14-Cre IKK2 fl/fl , which developed severe skin inflammation shortly after birth and died before P9 (Pasparakis et al., 2002) Figure 2A ; data not shown). We therefore reasoned that IKK2-deficient epidermal keratinocytes might trigger skin inflammation by producing factors attracting myeloid cells to the skin and analyzed the expression of several cytokines and chemokines in the epidermis of K14-Cre Ikk2 fl/fl mice during the first 4 days after birth. At P2, P3, and P4, we detected elevated transcript levels of CCL3, CCL4, and CCL5, as well as of IL-6 and GM-CSF in the epidermis of K14-Cre Ikk2 fl/fl mice compared to their WT littermates ( Figures 2B and 2C ). Because these proinflammatory mediators were not upregulated at P1, we asked whether their production was preceded and perhaps induced by an initiating factor. In an unbiased approach to detect this factor by using microarray analysis, we identified upregulation of IL-19 and IL-24 messenger RNA (mRNA) as early as P1 (data not shown), which was confirmed with qRT-PCR ( Figure 3A ). Because the epidermis of K14-Cre Ikk2 fl/fl mice does not contain increased numbers of myeloid cells at P1 and no expression of IL-19 and IL-24 could be detected in dermal RNA preparations ( Figure S2 ), epidermal keratinocytes are the major source of the elevated epidermal IL-19 and IL-24 mRNA. IL-19 and IL-24 were not upregulated in the epidermis of K14-Cre Ikk2 fl/fl mice at P0, suggesting that their expression is induced during the first 24 hr after birth. The increase in mRNA levels correlated with increased production of IL-24 protein, as revealed by immunoblot analysis of whole-skin protein lysates and by immunostaining of skin sections from K14-Cre Ikk2 fl/fl and control mice ( Figure 3B ). IL-20 and IL-22, two other members of the IL-10 cytokine family, were upregulated in the skin at P4 and P8, but not at P2 ( Figure 3C ). IL-19 and IL-24 bind to specific receptors, which signal via STAT3 (Dumoutier et al., 2001; Parrish-Novak et al., 2002) . Consistent with the elevated expression of IL-19 and IL-24, we detected increased nuclear staining for phosphorylated STAT3 in the epidermis of K14-Cre Ikk2 fl/fl , but not of control mice at P1, which was further increased at P3 ( Figure 3D ). Thus, early upregulation of IL-19 and IL-24 correlated with STAT3 activation in epidermal keratinocytes of K14-Cre Ikk2 fl/fl mice already at P1, a stage when no histological signs of skin inflammation can be detected in these animals. Considering that activation of STAT3 in keratinocytes induces psoriasis-like skin inflammation (Sano et al., 2005) , IL-19-and IL-24-mediated activation of STAT3 in the epidermis could provide the pathogenic signal that triggers skin inflammation in K14-Cre Ikk2 fl/fl mice. ( Figure 4A ), demonstrating that their expression was dependent on TNFR1 signaling. Consistent with these results, IL-24 upregulation in the skin of K5-IkBaSR mice was also induced by TNFR1 signaling in epidermal keratinocytes ( Figure 4B ). Although TNFR1 was required for the early upregulation of IL-24 in the NF-kB-deficient epidermis, we could not detect increased TNF mRNA in the skin of these animals during the first postnatal days ( Figure 4C ; data not shown). These results indicate that IL-24 upregulation in IKK2-deficient epidermis is not induced by increased TNF expression but rather by an aberrant response of keratinocytes to TNF concentrations present in normal skin. To investigate how TNFR1 signaling induces IL-24 expression in IKK2-deficient keratinocytes, we analyzed their response to TNF stimulation. As shown in Figure 4D , IKK2-deficient keratinocytes showed increased expression of IL-24 and GM-CSF but decreased expression of the NF-kB-dependent IL-6 gene in response to TNF stimulation compared to control cells. This response was specific for TNF because IL-1b stimulation did not induce increased IL-24 and GM-CSF expression in IKK2-deficient keratinocytes ( Figure 4E ). These in vitro findings confirm that upregulation of IL-24 and GM-CSF in epidermal keratinocytes of K14-Cre Ikk2 fl/fl mice is the result of an aberrant response to TNF. Because ERK activation was previously shown to regulate IL-24 expression (Yang et al., 2011) , we tested the involvement of ERK signaling in the upregulation of IL-24 and GM-CSF expression in IKK2-deficient keratinocytes. Inhibition Immunity TNF-IL-24 Axis in Psoriasis-like Skin Inflammation of MEK and ERK signaling by the specific MEK-1 and MEK-2 inhibitor UO126 suppressed the TNF-dependent expression of IL-24 and GM-CSF in both control and IKK2-deficient keratinocytes ( Figure 5A ). In addition, IKK2-deficient keratinocytes showed increased ERK phosphorylation after TNF stimulation compared to control keratinocytes ( Figure 5B ), suggesting that an overactivation of ERK signaling contributes to the increased IL-24 expression in these cells. NF-kB is proposed to limit TNF-dependent MAPK activation by inhibiting the accumulation of reactive oxygen species (ROS) (Sakon et al., 2003) . Indeed, IKK2-deficient keratinocytes had increased concentrations of ROS compared to control cells ( Figure 5C ), and treatment with the ROS scavenger N-acetylcysteine (NAC) strongly inhibited both TNF-induced ERK phosphorylation and IL-24 expression in IKK2-deficient and control keratinocytes ( Figures 5B and  5D ). Thus, TNF-induced IL-24 expression requires ROS-mediated activation of MEK and ERK signaling. 
K14-Cre Ikk2
fl/fl mice developed cutaneous inflammation to a variable degree, which affected their abdomen, the flanks, and the throat. Therefore, whereas ablation of IL-20R1 had a mild protective effect, IL-22R1 deficiency strongly inhibited, although it did not completely prevent, the development of inflammatory skin lesions in the K14-Cre Ikk2 fl/fl mice.
To address the potential role of IL-22, which also signals via IL-22R1 (Sabat, 2010) , we crossed the K14-Cre Ikk2 fl/fl mice to IL-22-deficient mice (Kreymborg et al., 2007) . Il22 À/À K14-Cre Ikk2 fl/fl mice developed severe inflammatory skin lesions and died before P9 similarly to K14-Cre Ikk2 fl/fl mice, demonstrating that IL-22 does not play an important pathogenic role in this model ( Figure S3B ).
The TNF-IL-24 Axis in Human Psoriasis
Overactivation of ERK and STAT3 signaling have been reported in psoriatic epidermis (Haase et al., 2001; Sano et al., 2005; Takahashi et al., 2002; Wolk et al., 2009a) , suggesting that the mechanism triggering skin inflammation in K14-Cre Ikk2 fl/fl mice could be relevant for human psoriasis. As shown previously and similar to K14-Cre Ikk2 fl/fl epidermis (see Figures 2 and 3) , we found that several cytokines and chemokines were upregulated in psoriatic epidermis, including IL-24, IL-19, IL-6, IL-1b, GM-CSF, and CCL4 ( Figures 7A and 7B ). In addition, consistent with our findings in K14-Cre Ikk2 fl/fl skin, TNF transcripts were upregulated in whole skin, but not in the epidermis of human psoriasis lesions ( Figures 7A and 7B ). To investigate whether the upregulation of IL-24 in human psoriatic epidermis could also be induced by an aberrant signaling response of human keratinocytes to TNF, we examined TNF-induced IL-24 expression in primary human keratinocytes treated with a highly specific IKK2 inhibitor, BI605906 (Clark et al., 2011) . Similar to IKK2-deficient murine keratinocytes, primary human keratinocytes showed increased expression of IL-24 mRNA and protein upon stimulation with TNF when pretreated with BI605906 ( Figure 7C ). Therefore, inhibition of IKK2-mediated NF-kB activation led to increased IL-24 expression in response to TNF stimulation in both mouse and human primary keratinocytes.
To examine whether IL-24 expression in psoriatic epidermis is driven by TNF, we measured IL-24 mRNA in the skin of psoriasis patients before and after treatment with anti-TNF antibodies. Anti-TNF therapy almost completely suppressed IL-24 expression in psoriatic skin, suggesting that IL-24 production is mainly driven by TNF in psoriasis ( Figure 7D ). To test whether IL-24 is capable to induce the expression of proinflammatory genes in human epidermis, we used a three dimensional (3D) human skin culture system (reconstituted human epidermis, RHE). As shown in Figure 7E , IL-24 stimulation induced the expression of many of the inflammatory mediators detected in psoriasis, including psoriasin, LCN2, IL-20, CXCL1, CXCL8, and CCL20. An increase in epidermal thickness was also observed in IL-24 stimulated compared to unstimulated RHE ( Figure S4 ). Taken together, our results suggest that TNF-driven IL-24 expression in keratinocytes contributes to the induction of inflammation in psoriasis, similar to our findings in the K14-Cre Ikk2
fl/fl mouse model.
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DISCUSSION
Our results presented here unravel a keratinocyte-intrinsic mechanism triggering psoriasis-like skin inflammation in mice with epidermis-specific NF-kB inhibition that is relevant for the understanding of the pathogenesis of psoriatic skin inflammation in humans. We show that TNFR1 signaling in IKK2-deficient epidermal keratinocytes is both necessary and sufficient for the development of skin inflammation, identifying skin epithelial cells as the major cellular target of the pathogenic TNF signals in this model. In addition, we identify TNFR1-induced, ROS-, and ERK-dependent expression of IL-24 in keratinocytes as a key early event contributing to skin inflammation. Our genetic experiments showing that IL-22R1 deficiency strongly ameliorated skin inflammation in K14-Cre Ikk2 fl/fl mice provide functional evidence for the key role of IL-24 as an early upstream cytokine inducing skin inflammation in this model. This is further supported by our findings that IL-20 and IL-22, which also signal via IL-22R1, were not upregulated at early stages of phenotype development. Indeed, IL-22 deficiency did not affect skin lesion development in these mice. However, although its expression pattern argues against a critical role in the initiation of skin inflammation in K14-Cre Ikk2 fl/fl mice, in the absence of functional evidence we cannot exclude that IL-20 also contributes to lesion development. Our findings are in line with recent results showing that transgenic expression of IL-24 in mouse epidermis was sufficient to induce skin inflammation (He and Liang, 2010) . In addition, the very mild protective effect of IL-20R1-deficiency suggests that IL-19, which signals exclusively via this receptor, is unlikely to play an important role in this type of skin inflammation, consistent with the findings that transgenic mice overexpressing IL-19 in the epidermis did not develop skin lesions (Parrish-Novak et al., 2002) . What is the relevance of our mouse model findings for the pathogenesis of human psoriasis? As shown recently (Wang et al., 2012) , we also found that IL-24, together with IL-19, was that pharmacological inhibition of IKK2-mediated NF-kB activation strongly increased TNF-induced IL-24 expression in primary human keratinocytes suggest that the TNF-dependent mechanism triggering skin inflammation in our mouse models is relevant for humans. Consistent with a recent study showing that anti-TNF treatment acutely suppressed the expression of IL-19, IL-20, and IL-24 in psoriatic epidermis (Wang et al., 2012) , we also detected downregulation of IL-24 expression in the skin of anti-TNF-treated psoriasis patients, suggesting that the epidermal keratinocyte is an important and direct cellular target of pathogenic TNF signaling also in human psoriasis. Our results in a human epidermis model showing that IL-24 strongly induces the expression of proinflammatory mediators known to be expressed in psoriatic skin also provide experimental evidence that IL-24 might act as an important upstream mediator in the pathogenesis of psoriatic skin inflammation, similarly to skin inflammation in our mouse models. There is still an ongoing debate concerning primary pathogenic functions of epidermal keratinocytes versus T lymphocytes in psoriasis, and there is evidence for both cell types playing important roles in disease development (Nickoloff et al., 2000) . Previously, a possible contribution of epidermal keratinocytes to the pathogenesis of psoriasis has been discussed primarily in the context of the dramatic changes in proliferation and differentiation that these cells undergo during disease development. Our results show that, in addition to their well-characterized role in epidermal hyperplasia, keratinocytes exhibit a potent capacity to initiate skin inflammation and could therefore be a crucial cellular component triggering the onset of the inflammatory response in psoriasis. More recent concepts of psoriasis pathogenesis allocate functions of different cell types to the changing phases of the disease process: it is thought that disease initiation is driven by innate immune responses, whereas T cell-dependent adaptive immune mechanisms take control in the maintenance phase (Nestle et al., 2009; Sabat et al., 2007) . We showed previously that the disease in K14-Cre Ikk2 fl/fl mice develops independently of ab T cells (Pasparakis et al., 2002) , suggesting that this model is more relevant for the innate immunity-driven initial phase of the disease. This concept is also compatible with our results that IL-24, but not IL-22, is critical for disease initiation. The idea of functional redundancies between these two cytokines in the development of psoriatic skin inflammation is tempting and is compatible with the two-phase model of the pathogenesis of psoriatic inflammation (Nestle et al., 2009; Sabat et al., 2007) . As IL-24 Immunity TNF-IL-24 Axis in Psoriasis-like Skin Inflammation is mainly produced by epithelial and innate immune cells and IL-22 by T-lymphocytes (Conti et al., 2003; Kunz et al., 2006; Ouyang et al., 2011; Zheng et al., 2007) , it is conceivable that IL-24 is particularly relevant for the initiation phase, whereas IL-22 could be mainly involved in the chronic phase of the disease. We therefore consider our mouse models as valuable for understanding the mechanisms governing the initiation phase of psoriasis-like skin inflammation. Anti-TNF therapy is currently one of the most effective treatments for psoriasis; however, the TNF-dependent mechanisms causing psoriatic inflammation are unknown. Our results suggest that epidermal keratinocytes are critical targets of pathogenic TNF signaling in psoriasis. Unexpectedly, it is not the upregulation of TNF expression but rather the deregulation of TNFR1 signaling that provides the pathogenic signal. In addition to NF-kB inhibition, other alterations disturbing TNF-TNFR1 signaling in epidermal keratinocytes also induced skin inflammation. For example, epidermis-specific FADD deficiency sensitizes keratinocytes to TNF-induced RIP kinase 3 (RIPK3)-mediated necrosis and spontaneously triggers severe skin inflammation in mice (Bonnet et al., 2011) . Given that a TNF-TNFR1-dependent surveillance mechanism is present in normal, resting skin, any intracellular change leading to altered TNFR1 signaling responses in epidermal keratinocytes could trigger the initiation of skin inflammation. This TNF-dependent surveillance mechanism could have an important physiological function to ensure the rapid induction of skin inflammation that is essential for host defense, wound healing, and tissue regeneration. The development of psoriatic lesions after wounding of the skin is a typical clinical characteristic of the disease known as Koebner phenomenon and could be explained by such a mechanism. Many polymorphisms that have been associated with psoriasis in genome-wide association studies lie within genes encoding proteins of the TNF-NF-kB signaling pathway or associated regulatory proteins (Jordan et al., 2012; Nair et al., 2009) . Although the functional consequences of these genetic polymorphisms are largely unknown, it is conceivable that some of these alleles could contribute to skin inflammation by altering TNFR signaling in epidermal keratinocytes.
Considering that chronic skin inflammation clinically identified as psoriasis most likely represents a range of diseases with distinct etiologies, it is likely that different mechanisms affecting the response of epidermal keratinocytes to TNF and most likely other immune surveillance mechanisms could trigger the disease. Indeed, previous studies showed that disturbance of different signaling pathways in keratinocytes can induce skin Immunity TNF-IL-24 Axis in Psoriasis-like Skin Inflammation inflammation, including activation of NF-kB (Rebholz et al., 2007) , MEK1/ERK (Hobbs et al., 2004; Hobbs and Watt, 2003) , or STAT3 signaling (Sano et al., 2005) and also inhibition of Jun-AP1 signaling (Zenz et al., 2005) . Because all of these pathways are involved in the regulation of keratinocyte reactions to stress, infection, or injury, it is tempting to hypothesize that deregulation of normal keratinocyte responses to environmental challenges could be a major pathogenic factor triggering the initiation of psoriatic inflammation. By identifying a keratinocyteintrinsic mechanism that links TNF, NF-kB, ERK, and STAT3 signaling with the initiation of psoriasis-like skin inflammation, our results provide an important step toward the better understanding of the pathogenesis of psoriasis.
EXPERIMENTAL PROCEDURES Mice
The following mouse lines were used: Ikk2 FL (Pasparakis et al., 2002) , K14-Cre (Hafner et al., 2004; Pasparakis et al., 2002) , Tnfr1 À/À , (Victoratos et al., 2006) , K5-IkBaSR (van Hogerlinden et al., 1999) , Kreymborg et al., 2007) , and Tnfr1 FL (Van Hauwermeiren et al., 2013) . IL-20R1 and IL-22R1 knockout mice will be described elsewhere. All animal procedures were conducted in accordance with European, national, and institutional guidelines, and protocols and were approved by local governmental authorities.
Immunostainings
Keratin staining on paraffin sections and CD11b, F4/80, Gr-1, CD3, and STAT-3 staining on cryosections were performed as described (Stratis et al., 2006) . IL-24 staining was performed on cryosections with anti-IL-24 antibodies (Santa Cruz Biotechnology). Details of the procedures are provided under Supplemental Experimental Procedures.
Isolation, Culture, and Stimulation of Keratinocytes Primary epidermal keratinocytes were isolated from newborn mice and cultured as described before (Tscharntke et al., 2007) . Primary human epidermal keratinocytes were obtained from Cascade Biologics and Promocell and cultured in KGM Gold Medium (Lonza). Cells were starved overnight in 1% FCS containing medium before stimulation with TNF or IL-1b. Inhibitors UO126 (EMD, Calbiochem), N-Acetyl-L-Cysteine (Sigma Aldrich), or Bl605906 (Clark et al., 2011) were added 1 hr prior to cell stimulation.
Reconstituted Human Epidermis Culture and Stimulation
Underdeveloped EpiDerm-201 reconstituted human epidermis (RHE) tissues composed of stratified human keratinocytes derived from neonatal foreskins were obtained from MatTek and were cultured as described previously (Wolk et al., 2011) . Briefly, they were cultured in inserts at the air-liquid interface with hydrocortisone-free Epi-201-DM differentiation medium (MatTek). For stimulation, culture medium was supplemented or not (control) with 20 ng/ml IL-24 (R&D Systems). After 72 hr, biopsies were taken from the tissues and either snap-frozen for histology (determination of thickness of the living cell layers) or lysed for mRNA analysis. 
Statistical Analysis
Statistical significance between in vivo-derived samples and in vitro-generated samples with different genotypes was determined with the unpaired Student's t test or the Mann-Whitney U-test (two-tailed) (*p < 0.05, **p < 0.01, ***p < 0.001). Paired in vitro generated samples were tested for significant differences between treatment groups with the Wilcoxon matched-pairs signed-rank test or paired student t test (two-tailed) (*p % 0.05, **p < 0.01, ***p < 0.001). Chapel Hill, USA), and was subcloned by blunt-end ligation into the SnaBI restriction site of the p59BK5 expression vector (Ramirez et al., 1994) , a kind gift from Professor José Jorcano (CIEMAT, Madrid, Spain). Tnfr1 -/-mice were kindly provided by Professor Tak At least 5 mice in every group were analyzed. Mice were kept according to Swedish national requirements and ethical permission was obtained for all experiments.
SUPPLEMENTAL INFORMATION
Isolation of skin cells and Flow Cytometry
Immune cells from whole skin of mice at P8 were isolated by a combination of enzymatic digestion and mechanical dissociation using liberase blendzyme 3 (Roche Applied Science) and BD TM Medimachine (BD Biosciences, San Jose, USA), respectively. The isolated cells were fluorescently labeled with primary antibodies;
anti-CD11b-APC (MACS, Miltenyi Biotech, 1:50), anti-F4/80-Alexa488 (Caltag, Invitrogen, 1:100), anti-CD11c-FITC (BD Pharmingen, 1:200) in FACS buffer (PBS, 2 mM EDTA and 0.5% BSA) for 30 minutes at 4°C. Primary epidermal keratinocytes, cultured in minimal calcium medium (0.05 mM) supplemented as previously described (Nenci et al., 2006) and dermal fibroblasts (grown in DMEM 10% FCS)
were stained with anti-TNFR1-APC (Biolegend, San Diego, CA) in PBS-BSA for 1 hour at 37°C (34°C for keratinocytes), then fixed in 4% PFA for 30 minutes at RT. For each sample a minimum of 20,000 cells were counted by flow cytometry. Non-viable cells were gated using 7AAD (BD Pharmingen).
Histopathological Analysis and Immunostainings
Tissue samples were excised and either fixed in 4% paraformaldehyde overnight, then embedded in paraffin or embedded freshly in OCT compound (Sakura, Netherlands). H&E-and Keratin-stainings were performed on sections of paraffin embedded skin which were de-paraffinized/ re-hydrated according to standard procedures and boiled in 1X target retrieval buffer, pH 6.0 (Dako) when applicable.
Biopsies taken from reconstituted human epidermis cultures were embedded in 
